Manufacturing

PD-1 Antibody Development Programs for Cancer Immunotherapy

Bispecific antibody, Cancer, Drug substance, Manufacturing, Monoclonal antibody

Scaling up Biologics Production at Mabion with Single-use Bioreactors and Automated Monitoring 

Biologics, Drug development, GMP, Mabion, Manufacturing

High-yield mAbs Manufacturing Platform Approach

Drug substance, Mabion, Manufacturing, Monoclonal antibody

Understanding the Role of Tech Transfer CDMOs in Biologics Manufacturing

Analytics, Biologics, GMP, Manufacturing, Regulatory

Robust Scale-down Model for Reliable Upstream Bioprocessing Scale-up

Drug substance, GMP, Mabion, Manufacturing

GMP Cell Banking as a Foundation of Safe Biologics Manufacturing

Biologics, Cell banking, GMP, Manufacturing

Cell Line Banking for Biologics Manufacturing

Biologics, Cell banking, Cell culture, Contamination, Manufacturing

Bioprocess Optimization Across Upstream and Downstream Processing

Drug development, Drug product, Drug substance, Manufacturing

Meeting Global Regulatory Standards in Biologic Drug Manufacturing Projects

Biologics, EMA, FDA, GMP, Mabion, Manufacturing, Regulatory